| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 02/14/2007 | EP1395554B1 Substituted carbazoles as inhibitors of spla2 |
| 02/14/2007 | EP1370552B1 Rho-kinase inhibitors |
| 02/14/2007 | EP1368349B1 Xanthine derivative, production and use thereof as a medicament |
| 02/14/2007 | EP1345928B1 Pyrazole compounds useful as protein kinase inhibitors |
| 02/14/2007 | EP1343757B1 Indole derivatives |
| 02/14/2007 | EP1328277B1 Bisphosphonic compounds for strengthening of cortical bone |
| 02/14/2007 | EP1296961B1 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 02/14/2007 | EP1280515B1 Pharmaceutical compositions comprising cannabis |
| 02/14/2007 | EP1267857B1 In vitro use of astaxanthin for pretreatment of cells prior to UV-exposure to inhibit the activation of NF-kB |
| 02/14/2007 | EP1259234B9 3-heteroarylidenyl-2-indolinone compounds for modulating protein kinase activity and for use in cancer chemotherapy |
| 02/14/2007 | EP1128813B1 An inhalation system |
| 02/14/2007 | EP1126836B1 Benzamide potassium channel inhibitors |
| 02/14/2007 | EP1124959B1 Cell surface molecule-induced macrophage activation |
| 02/14/2007 | CN1914168A Peptidyl arginine deiminase type IV inhibitor |
| 02/14/2007 | CN1914152A New compounds, methods for their preparation and use thereof |
| 02/14/2007 | CN1911965A Binding domain-immunoglobulin fusion proteins |
| 02/14/2007 | CN1911931A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease |
| 02/14/2007 | CN1911930A Chemokine receptor anagonists, methods and use therefor |
| 02/14/2007 | CN1911927A Substituted 2-(2,6-dioxopiperidin-3-yl)-phthalimides and -1-oxoisoindolines and method of reducing tnf alpha levels |
| 02/14/2007 | CN1911924A Extraction method of Nepal eagle tail isoflavone, its derivative and medicipal composition using said derivative as active component |
| 02/14/2007 | CN1911918A Kappa-opioid receptor agonist composed of 2-phenylbenzothiazoline derivative |
| 02/14/2007 | CN1911439A Orally administered peptides to ameliorate atherosclerosis |
| 02/14/2007 | CN1911438A 血管新生诱导剂 Angiogenic inducer |
| 02/14/2007 | CN1911433A Decoction for treating chirobrachialgia type cervical syndrome, and its prepn. method |
| 02/14/2007 | CN1911432A Decoction for treating choking sensation in chest type cervical syndrome, and its prepn. method |
| 02/14/2007 | CN1911426A Decoction for treating arthrophyma type rheumatoid arthritis, and its prepn. method |
| 02/14/2007 | CN1911425A Decoction for treating podomere funk-coldness type rheumatoid arthritis, and its prepn. method |
| 02/14/2007 | CN1911423A Decoction for treating sharp pain type rheumatoid arthritis, and its prepn. method |
| 02/14/2007 | CN1911420A Compound medicine prepn. for treating osteoporosis, and its prepn. method |
| 02/14/2007 | CN1911419A Medicinal composition for treating vertebrae lumbales hyperosteogeny |
| 02/14/2007 | CN1911415A Fuming and washing medicine for treating cold-dampness numbness type arthritis, and its prepn. method |
| 02/14/2007 | CN1911357A Medicinal composition for treating hyperosteogency |
| 02/14/2007 | CN1911353A Granule medicine contg. high oxygen with function for improving activity fo muscles and bones, and its supplementary skill exercise |
| 02/14/2007 | CN1911341A Traditional Chinese medicine prepn. for treating hyperosteogeny, and its external application prepn. |
| 02/14/2007 | CN1911338A Fuming and washing medicine for treating wind-damp numbness type arthritis, and its prepn. method |
| 02/14/2007 | CN1911337A Traditional Chinese medicine wine for treating cervical, lumbar vertebrae extruded disk and spinal stenosis |
| 02/14/2007 | CN1911294A Medicine for treating cervical spondylosis and lumba vertebrae disease |
| 02/14/2007 | CN1911293A Gel agent-Guzhining for treating osteoporosis and its prepn. method |
| 02/14/2007 | CN1911292A Medicated wine for treating rheumatismal arthritis and rheumatoid arthritis, and its prepn. method |
| 02/14/2007 | CN1911251A Traditional Chinese medicine enteric oral liquor using fresh earthworm extractive as active component, and its prepn. method |
| 02/14/2007 | CN1911225A Compound chlorazol fensuanna (Tongbixiao), and its prepn. method |
| 02/14/2007 | CN1300176C New saponin and its derivative, its preparation method and its use in medicine |
| 02/14/2007 | CN1300173C Human antibodies that bind huma TNF 'alpha' |
| 02/14/2007 | CN1300159C Ibuprofen sugar derivative and its preparing process and use |
| 02/14/2007 | CN1300155C Clycerophosphoinositol derivatives as modulators of cytosolic phospholipase |
| 02/14/2007 | CN1300114C Phenylpyridine carbonyl piperazine derivative |
| 02/14/2007 | CN1300113C Anthranilic acid amides and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/14/2007 | CN1299771C Colorstrum-based composition |
| 02/14/2007 | CN1299757C Chinese medicinal composition for treating scapulohumeral periarthritis and preparing method thereof |
| 02/14/2007 | CN1299754C Medicinal composition for treating theumalism and rheumatism diseases and preparing method thereof |
| 02/14/2007 | CN1299735C Chinese medicine for treating lumbar intervertebral disci protrasion and its preparing method |
| 02/14/2007 | CN1299721C Chinese herbal medicinal powder for treating atrophic arthritis |
| 02/14/2007 | CN1299713C External medicated wine of Chinese traditional medicine for curing gout |
| 02/14/2007 | CN1299711C Danlu traditional Chinese medicine tablet for treating lumbar vertebral canal stenosis and preparing method thereof |
| 02/14/2007 | CN1299709C Chinese medicne plaster for bone injury and its preparation method |
| 02/14/2007 | CN1299702C Preparation of medicine preparation of orthopedics department and its use |
| 02/14/2007 | CN1299689C Application of alendronate in preparation of drug for inhibitting bone resorption |
| 02/14/2007 | CN1299683C Celecoxib compositions |
| 02/14/2007 | CN1299672C Extracts from sophora,production method and purposes thereof |
| 02/13/2007 | US7176322 Bone disorders; hyperparathyroidism; such as N-((1-ethyl-3-phenyl-1H-indol-5-yl)methyl)-1-phenylethanamine |
| 02/13/2007 | US7176241 Aromatic or heteroaromatic compounds containing amide group are useful as inhibitor of dihydroorotate dehydrogenase |
| 02/13/2007 | US7176229 Pyrrolidine antiinflammatory agents for rheumatoid arthritis, osteoarthritis; antiallergens for asthma, chronic bronchitis, allergic rhinitis, adult respiratory distress syndrome, chronic pulmonary inflammatory disease; reduce or eliminate adverse CNS side effects associated with prior PDE4 inhibitors |
| 02/13/2007 | US7176227 Amine compounds and use thereof |
| 02/13/2007 | US7176217 such as N-Hydroxy-2-[(4-methoxyphenyl)sulfonyl]-2-azabicyclo[2.2.1]heptane-3-carboxamide, used in cosmetics or drugs as gelatinase inhibitors, for preventing skin aging or wrinkling; preventing diseases due to abnormal metabolism of tissue matrices such as arthritis, ulcers, metastasis or tumors |
| 02/13/2007 | US7176215 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 02/13/2007 | US7176213 For example, 1-(9-benzylamino-10-cyano-imidazo[1,2-a]quinolin-2-carbonyl)pyrrolidine; may be used for the treatment of diseases such as asthma, glaucoma, tumors, allergic and inflammatory diseases, ischemia, hypoxia, arrythmia and renal diseases |
| 02/13/2007 | US7176212 2,4-diamino pyrimidine compounds having anti-cell proliferative activity |
| 02/13/2007 | US7176202 Such as 2-chloro-N-(1-hydroxy-cycloheptylmethyl)-5-[4-(2-hydroxy-3-methoxy-propyl)-3,5-dioxo-4,5-dihydro-3H-[1,2,4]triazin-2-yl]-benzamide; purinergic receptors (P2x7 E); for treatment of interleukin-1 associated disorders, rheumatoid arthritis |
| 02/13/2007 | US7176199 Useful as a preventive or/and a therapeutic agent for a disease in which alpha v beta 3 integrin is involved |
| 02/13/2007 | US7176180 Fusion proteins; immunoglobulins; kits |
| 02/13/2007 | US7175997 BMP-11 compositions |
| 02/13/2007 | US7175850 Formulation for topical non-invasive application in vivo |
| 02/13/2007 | CA2191330C Meniscal augmentation device |
| 02/08/2007 | WO2007016285A2 M-csf specific monoclonal antibody and uses thereof |
| 02/08/2007 | WO2007016240A2 Use of antibody to m-csf |
| 02/08/2007 | WO2007015567A1 Cyclic amine compound |
| 02/08/2007 | WO2007014639A2 Method for isolating stem cells from cryopreserved dental tissue |
| 02/08/2007 | WO2007014454A1 Ep4 receptor agonist, compositions and methods thereof |
| 02/08/2007 | WO2006065975A8 Methods of treating ankylosing spondylitis using anti-tnf antibodies and peptides of human tumor necrosis factor |
| 02/08/2007 | WO2006063837A3 Use of bombesin/gastrin-releasing peptide antagonists for the treatment of inflammatory conditions, acute lung injury and bipolar disorder |
| 02/08/2007 | WO2006031375A3 Use of intradiscally administered autologous cells producing type i interferon for the treatment of degenerative disc disease |
| 02/08/2007 | US20070032653 N-{1-(4-(3-bromophenyl)-1H-imidazol-2-yl)-5-methylhexyl}-N-cyclohexylamine; agonists or antagonists of somatostatin receptors; acromegaly, restenosis, Crohn's disease, systemic sclerosis, external and internal pancreatic pseudocysts and ascites, nesidoblastosis, hyperinsulinism, gastrinoma, etc. |
| 02/08/2007 | US20070032640 Cytokine receptor |
| 02/08/2007 | US20070032518 Compounds and methods of use |
| 02/08/2007 | US20070032476 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof |
| 02/08/2007 | US20070032426 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders |
| 02/08/2007 | US20070031965 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism |
| 02/08/2007 | US20070031929 Polypeptides Homologous To VEGF and BMP1 |
| 02/08/2007 | US20070031523 purified plant extract for treating menopausal-syndrome; no side effect; ameliorating ovary function and regulating estrogen and progestogen, prevent many diseases due to imbalance of estrogen and progestrogen; for patients which need to use estrogen but with contraindication of hormone |
| 02/08/2007 | US20070031443 Methods for treating or preventing skin disorders using CD2-binding agents |
| 02/08/2007 | US20070031441 Immunotherapy based on dendritic cells |
| 02/08/2007 | US20070031421 Inhibitors targeting osteoclast-associated protein |
| 02/08/2007 | US20070031331 Treatment of Disorders |
| 02/08/2007 | CA2617541A1 Method for isolating stem cells from cryopreserved dental tissue |
| 02/08/2007 | CA2617256A1 Cyclic amine compound |
| 02/08/2007 | CA2616677A1 Cathepsin k inhibitors |
| 02/08/2007 | CA2616604A1 Ep4 receptor agonist, compositions and methods thereof |
| 02/07/2007 | EP1749884A1 Differentiation of bone marrow cells into neuronal cells and uses therefor |
| 02/07/2007 | EP1749520A1 Water-dispersible encapsulated sterols |
| 02/07/2007 | EP1748785A1 Modulation of cartilage homeostasis |